Enzymotec Ltd. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, services, research and therapies.
The company stated in its annual report that, “Pediatric drug development requires additional non-clinical work (such as animal studies in juvenile animals and additional reproductive toxicity work), as well as staged clinical work in determining safe dosing and monitoring.” (Page 12) Read the full document.
Enzymotec Ltd. engages in supplying of specialty lipid-based products and solutions. It develop, manufacture and market innovative bio-functional lipid ingredients, as well as final products, based on sophisticated proprietary processes and technologies. It operates through Nutrition and VAYA Pharma segments. The Nutrition segment develops, and manufactures nutritional ingredients for infant formulas and dietary supplements. The VAYA Pharma segment develops, manufactures, and sells branded lipid-based medical foods for the dietary management of medical disorders and common diseases. The company was founded on March 8, 1998 and is headquartered in Migdal HaEmeq, Israel. [Source: MarketWatch]
Company Website: http://www.enzymotec.com